Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Open accessThe DOI matches its Crossref record; 773 of the 831 references it cites were found in a registry or an index; 177 of the 559 sources its claims cite were checked for support.
Abstract
Congenital adrenal hyperplasia (CAH) is a group of autosomal recessive disorders affecting cortisol biosynthesis. Reduced activity of an enzyme required for cortisol production leads to chronic overstimulation of the adrenal cortex and accumulation of precursors proximal to the blocked enzymatic step. The most common form of CAH is caused by steroid 21-hydroxylase deficiency due to mutations in CYP21A2. Since the last publication summarizing CAH in Endocrine Reviews in 2000, there have been numerous new developments. These include more detailed understanding of steroidogenic pathways, refinements in neonatal screening, improved diagnostic measurements utilizing chromatography and mass spectrometry coupled with steroid profiling, and improved genotyping methods. Clinical trials of alternative medications and modes of delivery have been recently completed or are under way. Genetic and cell-based treatments are being explored. A large body of data concerning long-term outcomes in patients affected by CAH, including psychosexual well-being, has been enhanced by the establishment of disease registries. This review provides the reader with current insights in CAH with special attention to these new developments.
Overview
CoChat Summary
TL;DR
This review summarizes current understanding of congenital adrenal hyperplasia (CAH), predominantly 21-hydroxylase deficiency (21OHD), covering steroidogenesis, genetics, diagnosis, management, and long-term outcomes. It emphasizes a phenotypic continuum, newer biomarkers and therapies, and persistent evidence gaps in treatment and surgical care.
Key findings
- 21OHD accounts for approximately 90–99% of CAH; classic CAH incidence is about 1 in 14,000 to 18,000 by newborn screening, while nonclassic (NC) CAH is estimated at ~1 in 200 in the Caucasian population.
- Genotype correlates with the less severely impaired CYP21A2 allele: 96% of individuals with two Group 0 alleles have salt-wasting CAH, whereas 97% of those with at least one Group C allele have NC CAH; residual enzyme activity is ~1–5% in simple virilizing and ~20–50% in NC CAH.
- Long-term sequelae include testicular adrenal rest tumors (TARTs) in males (reported prevalence 14–86%, average 25% in adolescents and 46% in men), adrenal masses in ~20–30% of adults, and increased mortality; adrenal crises caused 42% of deaths in a Swedish cohort, with mean age at death 54.8 years versus 72.8 years in controls.
- Newer concepts include 11-oxo-androgens such as 11-ketotestosterone as biomarkers, the backdoor pathway to dihydrotestosterone, and novel therapies (CRHR1 antagonists, abiraterone, modified-release hydrocortisone, gene/cell-based approaches), though many lack peer-reviewed long-term outcomes.
Methods
- Narrative, multi-authored review resulting from a planned European CAH Symposium postponed due to the COVID-19 pandemic; it covers pathophysiology, diagnostics, management, long-term sequelae, developing-country challenges, and future directions.
- Evidence base is a synthesis of published literature, clinical guidelines (including the 2018 Endocrine Society guideline), registries, observational studies, meta-analyses, and clinical trials; no primary patient cohort or systematic search is described.
- Main analysis is narrative synthesis, with tables and figures summarizing incidence, allele frequencies, treatment dosing, monitoring, and prenatal dexamethasone outcomes.
Limitations
- Stated: there are no large-scale prospective randomized trials for any therapies discussed; evidence is generally low or moderate quality and rests partly on expert opinion, values, and preferences.
- Stated: no evidence-based guidelines for surgical management exist, and there are no studies comparing different feminizing surgery techniques or early versus late surgery; genotype-phenotype correlations are strong but not absolute, and many neuroimaging studies are hindered by small sample size.
- Evident: as a narrative review, it does not report a systematic search strategy, formal risk-of-bias assessment, or quantitative synthesis; conclusions depend on the cited literature and expert consensus.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
86 Valid · 78 Not valid · 186 Not checked · 76 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Supraphysiological dosages of glucocorticoids similar to those used to treat classic CAH patients may be necessary to suppress adrenal androgen production (426).”
§ Congenital adrenal hyperplasia -current insights in pathophysiology, diagnostics and management > Growth
What the sources say
- Disputedcites [426] Livadas, 2019, Management of the female with non-classical congenital adrenal hyperplasia (NCCAH): a patient-oriented approach, Front Endocrinol (Lausanne). sourceExperimental — accuracy not yet measured
In “NCCAH Management From the First Manifestation to the Adult Life” (page unavailable), the paper says glucocorticoids are generally given at replacement, not pharmacological, doses to decrease adrenal androgen production. Its “Management During Childhood” section adds that very high doses are needed to suppress 17-OHP and progesterone, not that supraphysiological doses are necessary to suppress adrenal androgens. (LLM, conf=0.87)
Checked by a reasoning model — may be wrong.
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Females do outnumber males in some(12,240,241) although not all (242) retrospective studies in which CAH was clinically diagnosed without neonatal screening.”
§ Congenital adrenal hyperplasia -current insights in pathophysiology, diagnostics and management > Table 7
What the sources say
- Not checked — no full text of the sourcecites [12] Dumic, 2009, Classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Croatia between 1995 and 2006, Horm Res. source
- Not checked — no full text of the sourcecites [240] Hird, 2014, No evidence of an increase in early infant mortality from congenital adrenal hyperplasia in the absence of screening, Arch Dis Child. source
- Disputedcites [241] Riedl, 2019, Genotype/phenotype correlations in 538 congenital adrenal hyperplasia patients from Germany and Austria: discordances in milder genotypes and in screened versus prescreening patients, Endocr Connect. sourceExperimental — accuracy not yet measured
Citation (242) is attached to “not all,” offering this study as an example of a retrospectively studied, clinically diagnosed prescreening group without a female majority. The Results (Eligible patients; page unavailable) say the opposite: females made up 64% of the prescreening group. The approximately equal sex distribution was in the screened group, which does not fit that clause. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“A single-dose, fixed-sequence study of 8 women given 300 or 600 mg of the CRHR1 antagonist NBI77860 at 2200 (10 PM) showed significant reductions in ACTH and 17OHP over the ensuing 16 hours relative to a control period during which glucocorticoid treatment was withheld (498).”
§ Congenital adrenal hyperplasia -current insights in pathophysiology, diagnostics and management > D. New medical strategies (Figure 5)
What the sources say
- Disputedcites [498] Sanders, 2018, Melanocortin 2 receptor antagonists in canine pituitary-dependent hypercortisolism: in vitro studies, Vet Res Commun. sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 0 partially supported, 2 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Checked by a reasoning model — may be wrong.
plainstates a causen = 8- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Excessive nighttime glucocorticoid administration has potential adverse metabolic consequences (371,382).”
§ Congenital adrenal hyperplasia -current insights in pathophysiology, diagnostics and management > Table 7
What the sources say
- Not checked — no full text of the sourcecites [371] Han, 2013, Glucocorticoid treatment regimen and health outcomes in adults with congenital adrenal hyperplasia, Clin Endocrinol (Oxf). source
- Partly supportedcites [382] Whitaker, 2014, An oral multiparticulate, modified-release, hydrocortisone replacement therapy that provides physiological cortisol exposure, Clin Endocrinol (Oxf). sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) says cortisol is normally low around midnight and that loss of its rhythm is associated with insulin resistance. It also suggests physiological replacement may help metabolic homeostasis. These passages support a potential metabolic concern, but the paper does not specifically state that excessive nighttime glucocorticoid administration has adverse metabolic consequences. (LLM, conf=0.82)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Low expression of CYP21A2 during the second trimester partially explains the high incidence of false-positives in newborn screens for CAH in premature infants (see section IV.A)(159).”
§ Congenital adrenal hyperplasia -current insights in pathophysiology, diagnostics and management > Pattern of CYP21A2 expression
What the sources say
- Could not verifycites [159] Zhou, 1997, Steroid 21-hydroxylase expression and activity in human lymphocytes, Mol Cell Endocrinol. sourceExperimental — accuracy not yet measured
Section 3.1 reports CYP21 expression in cultured lymphoid cells, including cells from CAH patients, but does not examine expression during the second trimester. Searches for premature infants, newborn screening, and false positives found no passage addressing the proposed explanation. (LLM, conf=0.76)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
207 more claims · 72 with their cited sources checked
Create a free account to see all 426 claims and to verify the 50 references still open.
- It may state two separate claims as one. 172
- Probably not a substantial claim. 64
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It has been reported that heterozygous TNXB mutations may be associated with the mild joint hypermobility form of EDS [1, 15] and that up to 10% of classic SW-CAH patients harboring in compound heterozygosity a TNXB/CYP21A2 genotype tend to demonstrate an extended phenotype termed CAH-X syndrome [1, 31, 32] (Fig. 2).”
From Salt-wasting congenital adrenal hyperplasia phenotype as a result of the TNXA/TNXB chimera 1 (CAH-X CH-1) and the pathogenic IVS2-13A/C > G in CYP21A2 gene (2023) · cites this paper as [1]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It has been reported that heterozygous TNXB mutations may be associated with the mild joint hypermobility form of EDS [1, 15] and that up to 10% of classic SW-CAH patients harboring in compound heterozygosity a TNXB/CYP21A2 genotype tend to demonstrate an extended phenotype termed CAH-X syndrome [1, 31, 32] (Fig. 2).”
From Salt-wasting congenital adrenal hyperplasia phenotype as a result of the TNXA/TNXB chimera 1 (CAH-X CH-1) and the pathogenic IVS2-13A/C > G in CYP21A2 gene (2023) · cites this paper as [1]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Several reports in European, Mediterranean, Middle Eastern, and Chinese populations confirmed a high frequency of the pathogenic IVS2-13A/C > G and found it to comprise 20 to 25% of the CYP21A2 mutant alleles and to translate to the most severe SW forms of the disease when inherited in homozygosity [1, 4, 27, 39–43].”
From Salt-wasting congenital adrenal hyperplasia phenotype as a result of the TNXA/TNXB chimera 1 (CAH-X CH-1) and the pathogenic IVS2-13A/C > G in CYP21A2 gene (2023) · cites this paper as [1]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“When combined with complementary methods such MLPA for copy number analysis, it provides nearly complete diagnostic coverage, identifying up to 98-99% of classical pathogenic alleles in most populations (1, 16, 76).”
From Evolution of molecular diagnostic strategies for 21-hydroxylase deficiency: from classical methods to advanced genomic techniques (2026) · cites this paper as [76]
In the citing paper
“Although CAH is rare, the most common form is caused by steroid 21-hydroxylase deficiency (21-OHD) and is an autosomal-recessive disorder of adrenal steroidogenesis that results from CYP21A2 mutations.”
From Management challenges and therapeutic advances in congenital adrenal hyperplasia (2022) · cites this paper as [1]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“Sodium chloride supplements 1-2 g (17-24 mEq/day) in infancy”
§ Congenital adrenal hyperplasia -current insights in pathophysiology, diagnostics and management > Graphical Abstract
Reported 24 · recomputed 34
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“A recent meta-analysis of 48 CAH cases, 34 (71%) described symptomatic improvement after bilateral adrenalectomy but with 34 cases (10%) reporting short-term and 13 cases (27%) long-term adverse outcomes”
§ Congenital adrenal hyperplasia -current insights in pathophysiology, diagnostics and management > D. New medical strategies (Figure 5)
Reported 10 · recomputed 70.833333
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Presence of fetal DNA in maternal plasma and serum
Lo, Y. M. D., Corbetta, N., Chamberlain, P. F., Rai, V., Sargent, I. L., Redman, C. W., & Wainscoat, J. S. (1997) · The Lancet · doi:10.1016/s0140-6736(97)02174-0 · Cited by 3,129
The Hypothalamic–Pituitary–Adrenal Axis and Immune-Mediated Inflammation
Chrousos, G. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322008 · Cited by 2,579
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
Self-citationConsensus Statement on Management of Intersex Disorders
Lee, P. A., Houk, C. P., Ahmed, S. F., Hughes, I. A., & in collaboration with the participants in the International Consensus Conference on Intersex organized by the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology (2006) · Pediatrics · doi:10.1542/peds.2006-0738 · Cited by 2,324
Self-citationBornstein, S. R., Allolio, B., Arlt, W., Barthel, A., Don-Wauchope, A., Hammer, G. D., Husebye, E. S., Merke, D. P., Murad, M. H., Stratakis, C. A., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1710 · Cited by 1,769
Self-citationAromatase Cytochrome P450, The Enzyme Responsible for Estrogen Biosynthesis*
SIMPSON, E. R., MAHENDROO, M. S., MEANS, G. D., KILGORE, M. W., HINSHELWOOD, M. M., GRAHAM-LORENCE, S., AMARNEH, B., ITO, Y., FISHER, C. R., MICHAEL, M. D., et al. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-3-342 · Cited by 1,537
Size and burden of mental disorders in Europe—a critical review and appraisal of 27 studies
Wittchen, H.-U., & Jacobi, F. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.04.012 · Cited by 1,503
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468
Self-citationCongenital adrenal hyperplasia due to 21-hydroxylase deficiency*
White, P. C., & Speiser, P. W. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.3.0398 · Cited by 1,432
Self-citationSexual dimorphism of brain developmental trajectories during childhood and adolescence
Lenroot, R. K., Gogtay, N., Greenstein, D. K., Wells, E. M., Wallace, G. L., Clasen, L. S., Blumenthal, J. D., Lerch, J., Zijdenbos, A. P., Evans, A. C., et al. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.03.053 · Cited by 1,309
Use of Inhaled Corticosteroids and Risk of Fractures
Van Staa, T. P., Leufkens, H. G. M., & Cooper, C. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.3.581 · Cited by 1,308
The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis
Staa, T. P. V., Staa, T. P. V., Staa, T. P. V., Leufkens, H. G. M., & Cooper, C. (2002) · Osteoporosis International · doi:10.1007/s001980200108 · Cited by 1,294
Global Disorders of Sex Development Update since 2006: Perceptions, Approach and Care
Lee, P. A., Nordenström, A., Houk, C. P., Ahmed, S. F., Auchus, R., Baratz, A., Baratz Dalke, K., Liao, L.-M., Lin-Su, K., Looijenga 3rd, L. H. J., et al. (2016) · Hormone Research in Paediatrics · doi:10.1159/000442975 · Cited by 1,273
Self-citationMale fetal progenitor cells persist in maternal blood for as long as 27 years postpartum
Bianchi, D. W., Zickwolf, G. K., Weil, G. J., Sylvester, S., & DeMaria, M. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.2.705 · Cited by 1,264
Use of oral corticosteroids and risk of fractures
Van Staa, T. P., Leufkens, H. G. M., Abenhaim, L., Zhang, B., & Cooper, C. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.6.993 · Cited by 1,263
Twenty-four hour pattern of the episodic secretion of cortisol in normal subjects
WEITZMAN, E. D., FUKUSHIMA, D., NOGEIRE, C., ROFFWARG, H., GALLAGHER, T. F., & HELLMAN, L. (1971) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-33-1-14 · Cited by 1,258
Speiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
Self-citationSex differences in the structural connectome of the human brain
Ingalhalikar, M., Smith, A., Parker, D., Satterthwaite, T. D., Elliott, M. A., Ruparel, K., Hakonarson, H., Gur, R. E., Gur, R. C., & Verma, R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1316909110 · Cited by 1,223
Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis
Lin, D., Sugawara, T., Strauss, J. F., Clark, B. J., Stocco, D. M., Saenger, P., Rogol, A., & Miller, W. L. (1995) · Science · doi:10.1126/science.7892608 · Cited by 1,030
Self-citationCongenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
White, P. C. (2000) · Endocrine Reviews · doi:10.1210/er.21.3.245 · Cited by 877
Self-citationParenting stress among caregivers of children with chronic illness: a systematic review
Cousino, M. K., & Hazen, R. A. (2013) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jst049 · Cited by 873
Borg, B. (1994) · Comparative Biochemistry and Physiology Part C: Pharmacology, Toxicology and Endocrinology · doi:10.1016/0742-8413(94)00063-g · Cited by 857
Sex Differences in the Adult Human Brain: Evidence from 5216 UK Biobank Participants
Ritchie, S. J., Cox, S. R., Shen, X., Lombardo, M. V., Reus, L. M., Alloza, C., Harris, M. A., Alderson, H. L., Hunter, S., Neilson, E., et al. (2018) · Cerebral Cortex · doi:10.1093/cercor/bhy109 · Cited by 855
Owens, P. C., Smith, R., Brinsmead, M. W., Hall, C., Rowley, M., Hurt, D., Lovelock, M., Chan, E.-C., Cubis, J., & Lewin, T. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90603-5 · Cited by 847
Steroidogenic factor 1: a key determinant of endocrine development and function
Parker, K. L., & Schimmer, B. P. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.3.0301 · Cited by 764
The pathophysiology and genetics of congenital lipoid adrenal hyperplasia
Bose, H. S., Sugawara, T., Strauss, J. F., & Miller, W. L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612193352503 · Cited by 676
Self-citationCongenital adrenal hyperplasia
El-Maouche, D., Arlt, W., & Merke, D. P. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31431-9 · Cited by 669
Self-citationPENNING, T. M., BURCZYNSKI, M. E., JEZ, J. M., HUNG, C.-F., LIN, H.-K., MA, H., MOORE, M., PALACKAL, N., & RATNAM, K. (2000) · Biochemical Journal · doi:10.1042/bj3510067 · Cited by 649
Congenital adrenal hyperplasia.
Merke, D. P., & Bornstein, S. R. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66736-0 · Cited by 628
Self-citationMolecular biology of the 3β-hydroxysteroid dehydrogenase/Δ5-Δ4 –isomerase gene family
Simard, J., Ricketts, M.-L., Gingras, S., Soucy, P., Feltus, F. A., & Melner, M. H. (2005) · Endocrine Reviews · doi:10.1210/er.2002-0050 · Cited by 620
Current status of newborn screening worldwide: 2015
Therrell, B. L., Padilla, C. D., Loeber, J. G., Kneisser, I., Saadallah, A., Borrajo, G. J. C., & Adams, J. (2015) · Seminars in Perinatology · doi:10.1053/j.semperi.2015.03.002 · Cited by 602
Nyirenda, M. J., Lindsay, R. S., Kenyon, C. J., Burchell, A., & Seckl, J. R. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1567 · Cited by 574
Speiser, P. W., Dupont, J., Zhu, D., Serrat, J., Buegeleisen, M., Tusie-Luna, M. T., Lesser, M., New, M. I., & White, P. C. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115897 · Cited by 572
Self-citationStructure of human steroid 21-hydroxylase genes.
White, P. C., New, M. I., & Dupont, B. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.14.5111 · Cited by 569
Self-citationHigashi, Y., Yoshioka, H., Yamane, M., Gotoh, O., & Fujii-Kuriyama, Y. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.9.2841 · Cited by 555
Cytochrome b 5 Augments the 17,20-Lyase Activity of Human P450c17 without Direct Electron Transfer
Auchus, R. J., Lee, T. C., & Miller, W. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3158 · Cited by 541
Self-citation11β-Hydroxysteroid Dehydrogenase and the Syndrome of Apparent Mineralocorticoid Excess*
White, P. C., Mune, T., & Agarwal, A. K. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0288 · Cited by 517
Self-citationMutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome
Flück, C. E., Tajima, T., Pandey, A. V., Arlt, W., Okuhara, K., Verge, C. F., Jabs, E. W., Mendonça, B. B., Fujieda, K., & Miller, W. L. (2004) · Nature Genetics · doi:10.1038/ng1300 · Cited by 509
Self-citationHealth status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients
Arlt, W., Willis, D. S., Wild, S. H., Krone, N., Doherty, E. J., Hahner, S., Han, T. S., Carroll, P. V., Conway, G. S., Rees, D. A., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0917 · Cited by 506
Self-citationBrain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques. I. Hippocampus
Uno, H., Lohmiller, L., Thieme, C., Kemnitz, J. W., Engle, M. J., Roecker, E. B., & Farrell, P. M. (1990) · Developmental Brain Research · doi:10.1016/0165-3806(90)90002-g · Cited by 502
White, P. C., Grossberger, D., Onufer, B. J., Chaplin, D. D., New, M. I., Dupont, B., & Strominger, J. L. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.4.1089 · Cited by 490
Self-citationPathogenesis of glucocorticoid-induced osteoporosis and options for treatment
Chotiyarnwong, P., & McCloskey, E. V. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0341-0 · Cited by 489
Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis
Simpson, E. R. (1994) · Endocrine Reviews · doi:10.1210/er.15.3.342 · Cited by 482
(2002) · Hormone Research in Paediatrics · doi:10.1159/000065490 · Cited by 458
Self-citationSchiffer, L., Barnard, L., Baranowski, E. S., Gilligan, L. C., Taylor, A. E., Arlt, W., Shackleton, C. H. L., & Storbeck, K.-H. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105439 · Cited by 450
Self-citationMolecular Endocrinology of Hydroxysteroid Dehydrogenases*
Penning, T. M. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.3.0302 · Cited by 438
Gender dysphoria and gender change in chromosomal females with congenital adrenal hyperplasia
Dessens, A. B., Slijper, F. M. E., & Drop, S. L. S. (2005) · Archives of Sexual Behavior · doi:10.1007/s10508-005-4338-5 · Cited by 425
Husebye, E. S., Allolio, B., Arlt, W., Badenhoop, K., Bensing, S., Betterle, C., Falorni, A., Gan, E. H., Hulting, A. ‐., Kasperlik‐Zaluska, A., et al. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12162 · Cited by 403
Self-citationKrone, N., Braun, A., Roscher, A. A., Knorr, D., & Schwarz, H. P. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.3.6441 · Cited by 397
Self-citationHahner, S., Spinnler, C., Fassnacht, M., Burger-Stritt, S., Lang, K., Milovanovic, D., Beuschlein, F., Willenberg, H. S., Quinkler, M., & Allolio, B. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3191 · Cited by 394
Behavior Problems in Children and Adolescents With Chronic Physical Illness: A Meta-Analysis
Pinquart, M., & Shen, Y. (2011) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsr042 · Cited by 371
Wedell, A. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.5.1145 · Cited by 370
Psychological interventions for parents of children and adolescents with chronic illness
Eccleston, C., Palermo, T. M., Fisher, E., & Law, E. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009660.pub2 · Cited by 369
Estrogen: Consequences and Implications of Human Mutations in Synthesis and Action1
Grumbach, M. M., & Auchus, R. J. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.12.6290 · Cited by 368
Salomon, L. J., Sotiriadis, A., Wulff, C. B., Odibo, A., & Akolekar, R. (2019) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.20353 · Cited by 367
Tenascin-X deficiency is associated with Ehlers-Danlos syndrome
Burch, G. H., Gong, Y., Liu, W., Dettman, R. W., Curry, C. J., Smith, L., Miller, W. L., & Bristow, J. (1997) · Nature Genetics · doi:10.1038/ng0997-104 · Cited by 366
Self-citationNew, M. I., Abraham, M., Gonzalez, B., Dumic, M., Razzaghy-Azar, M., Chitayat, D., Sun, L., Zaidi, M., Wilson, R. C., & Yuen, T. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300057110 · Cited by 365
The product of the CYP11B2 gene is required for aldosterone biosynthesis in the human adrenal cortex
Curnow, K. M., Tusie-Luna, M.-T., Pascoe, L., Natarajan, R., Gu, J.-L., Nadler, J. L., & White, P. C. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-10-1513 · Cited by 362
Self-citationThe backdoor pathway to dihydrotestosterone
Auchus, R. J. (2004) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2004.09.004 · Cited by 347
Self-citationArlt, W., Walker, E. A., Draper, N., Ivison, H. E., Ride, J. P., Hammer, F., Chalder, S. M., Borucka-Mankiewicz, M., Hauffa, B. P., Malunowicz, E. M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16503-3 · Cited by 345
Self-citationTherrell, B. L., Berenbaum, S. A., Manter-Kapanke, V., Simmank, J., Korman, K., Prentice, L., Gonzalez, J., & Gunn, S. (1998) · Pediatrics · doi:10.1542/peds.101.4.583 · Cited by 344
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Merke, D. P., & Auchus, R. J. (2020) · New England Journal of Medicine · doi:10.1056/nejmra1909786 · Cited by 341
Self-citationLong-term outcomes after repeat doses of antenatal corticosteroids
Wapner, R. J., Sorokin, Y., Mele, L., Johnson, F., Dudley, D. J., Spong, C. Y., Peaceman, A. M., Leveno, K. J., Malone, F., Caritis, S. N., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071453 · Cited by 336
Huang, N., Pandey, A. V., Agrawal, V., Reardon, W., Lapunzina, P. D., Mowat, D., Jabs, E. W., Vliet, G. V., Sack, J., Flück, C. E., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/429417 · Cited by 336
Self-citationJohannsson, G., Nilsson, A. G., Bergthorsdottir, R., Burman, P., Dahlqvist, P., Ekman, B., Engström, B. E., Olsson, T., Ragnarsson, O., Ryberg, M., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1926 · Cited by 329
Borg, B. (1994) · Comparative Biochemistry and Physiology Part C Pharmacology Toxicology and Endocrinology · doi:10.1016/1367-8280(94)90135-x · Cited by 328
Räikkönen, K., Gissler, M., & Kajantie, E. (2020) · JAMA · doi:10.1001/jama.2020.3937 · Cited by 327
Meyer-Bahlburg, H. F. L., Dolezal, C., Baker, S. W., & New, M. I. (2008) · Archives of Sexual Behavior · doi:10.1007/s10508-007-9265-1 · Cited by 326
Barriers to transition from pediatric to adult care: a systematic review
Gray, W. N., Schaefer, M. R., Resmini-Rawlinson, A., & Wagoner, S. T. (2018) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsx142 · Cited by 326
Minireview: Regulation of Steroidogenesis by Electron Transfer
Miller, W. L. (2005) · Endocrinology · doi:10.1210/en.2005-0096 · Cited by 324
Self-citationModified-release hydrocortisone to provide circadian cortisol profiles
Debono, M., Ghobadi, C., Rostami-Hodjegan, A., Huatan, H., Campbell, M. J., Newell-Price, J., Darzy, K., Merke, D. P., Arlt, W., & Ross, R. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2380 · Cited by 322
Self-citationNew, M. I., Tong, Y. K., Yuen, T., Jiang, P., Pina, C., Chan, K. C. A., Khattab, A., Liao, G. J. W., Yau, M., Kim, S.-M., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1118 · Cited by 319
The genetic and functional basis of isolated 17,20 lyase deficiency
Geller, D. H., Auchus, R. J., Mendonça, B. B., & Miller, W. L. (1997) · Nature Genetics · doi:10.1038/ng1097-201 · Cited by 318
Self-citationNonclassical 21-Hydroxylase Deficiency
New, M. I. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1645 · Cited by 315
Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia
Finkielstain, G. P., Kim, M. S., Sinaii, N., Nishitani, M., Van Ryzin, C., Hill, S. C., Reynolds, J. C., Hanna, R. M., & Merke, D. P. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2102 · Cited by 313
Self-citationLindsay, R. S., Lindsay, R. M., Edwards, C. R. W., & Seckl, J. R. (1996) · Hypertension · doi:10.1161/01.hyp.27.6.1200 · Cited by 310
Creighton, S. M., Minto, C. L., & Steele, S. J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05343-0 · Cited by 303
Tenascin-X: a novel extracellular matrix protein encoded by the human XB gene overlapping P450c21B
Bristow, J., Tee, M., Gitelman, S., Mellon, S., & Miller, W. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.1.265 · Cited by 302
Self-citationEstrogen: Consequences and Implications of Human Mutations in Synthesis and Action
Grumbach, M. M. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.12.4677 · Cited by 298
PANG, S., HOTCHKISS, J., DRASH, A. L., LEVINE, L. S., & NEW, M. I. (1977) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-45-5-1003 · Cited by 293
In humans, early cortisol biosynthesis provides a mechanism to safeguard female sexual development
Goto, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25091 · Cited by 284
Lindsay, R. S., Lindsay, R. M., Waddell, B. J., & Seckl, J. R. (1996) · Diabetologia · doi:10.1007/s001250050573 · Cited by 283
Prevalence and stability of mental disorders among young adults: findings from a longitudinal study
Gustavson, K., Knudsen, A. K., Nesvåg, R., Knudsen, G. P., Vollset, S. E., & Reichborn-Kjennerud, T. (2018) · BMC Psychiatry · doi:10.1186/s12888-018-1647-5 · Cited by 282
Frisén, L., Nordenström, A., Falhammar, H., Filipsson, H., Holmdahl, G., Janson, P. O., Thorén, M., Hagenfeldt, K., Möller, A., & Nordenskjöld, A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0636 · Cited by 276
Self-citationDisorders of Steroid 11β-Hydroxylase Isozymes*
WHITE, P. C., CURNOW, K. M., & PASCOE, L. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-4-421 · Cited by 271
Self-citationMinireview: steroidogenic factor 1: its roles in differentiation, development, and disease
Schimmer, B. P., & White, P. C. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0519 · Cited by 268
Adrenomedullary dysplasia and hypofunction in patients with classic 21-hydroxylase deficiency.
Merke, D. P., Chrousos, G. P., Eisenhofer, G., Weise, M., Keil, M. F., Rogol, A. D., Van Wyk, J. J., & Bornstein, S. R. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011093431903 · Cited by 266
Self-citationTHE GENETICS, PATHOPHYSIOLOGX, AND MANAGEMENT OF HUMAN DEFICIENCIES OF P450c17
Auchus, R. J. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(08)70021-5 · Cited by 266
Self-citationNew, M. I., Carlson, A., Obeid, J., Marshall, I., Cabrera, M. S., Goseco, A., Lin-Su, K., Putnam, A. S., Wei, J. Q., & Wilson, R. C. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.12.8072 · Cited by 263
Rushworth, R. L., Torpy, D. J., & Falhammar, H. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1807486 · Cited by 262
Self-citationDirect lineage conversions: unnatural but useful?
Vierbuchen, T., & Wernig, M. (2011) · Nature Biotechnology · doi:10.1038/nbt.1946 · Cited by 259
Maerker, T., van Wijk, E., Overlack, N., Kersten, F. F. J., McGee, J., Goldmann, T., Sehn, E., Roepman, R., Walsh, E. J., Kremer, H., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddm285 · Cited by 259
Effect of corticosteroids on brain growth in fetal sheep
Huang, W. (1999) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(99)00265-3 · Cited by 258
Nordenström, A., Servin, A., Bohlin, G., Larsson, A., & Wedell, A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2001-011531 · Cited by 256
Self-citationTusie-Luna, M. T., Traktman, P., & White, P. C. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)45304-x · Cited by 254
Self-citationNovel findings from 2,838 Adult Brains on Sex Differences in Gray Matter Brain Volume
Lotze, M., Domin, M., Gerlach, F. H., Gaser, C., Lueders, E., Schmidt, C. O., & Neumann, N. (2019) · Scientific Reports · doi:10.1038/s41598-018-38239-2 · Cited by 252
Mutation in the CYP21B gene (Ile-172-Asn) causes steroid 21-hydroxylase deficiency
Amor, M., Parker, K. L., Globerman, H., New, M. I., & White, P. C. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.5.1600 · Cited by 251
Self-citationExtensive expertise in endocrinology: adrenal crisis
Allolio, B. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-0824 · Cited by 251
Bancos, I., Taylor, A. E., Chortis, V., Sitch, A. J., Jenkinson, C., Davidge-Pitts, C. J., Lang, K., Tsagarakis, S., Macech, M., Riester, A., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30218-7 · Cited by 250
Self-citationCrouch, N. S., Liao, L. M., Woodhouse, C. R. J., Conway, G. S., & Creighton, S. M. (2008) · Journal of Urology · doi:10.1016/j.juro.2007.09.079 · Cited by 249
Flück, C. E., Meyer-Böni, M., Pandey, A. V., Kempná, P., Miller, W. L., Schoenle, E. J., & Biason-Lauber, A. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.06.009 · Cited by 248
Self-citationNoninvasive Fetal Sex Determination Using Cell-Free Fetal DNA: A Systematic Review and Meta-analysis
Devaney, S. A., Palomaki, G. E., Scott, J. A., & Bianchi, D. W. (2011) · JAMA · doi:10.1001/jama.2011.1114 · Cited by 247
The orphan nuclear receptor NGFI-B regulates expression of the gene encoding steroid 21-hydroxylase.
Wilson, T. E., Mouw, A. R., Weaver, C. A., Milbrandt, J., & Parker, K. L. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.2.861 · Cited by 246
Higashi, Y., Tanae, A., Inoue, H., Hiromasa, T., & Fujii-Kuriyama, Y. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.20.7486 · Cited by 244
de Vries, A., Holmes, M. C., Heijnis, A., Seier, J. V., Heerden, J., Louw, J., Wolfe-Coote, S., Meaney, M. J., Levitt, N. S., & Seckl, J. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30982 · Cited by 241
Neonatal screening for congenital adrenal hyperplasia
White, P. C. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.148 · Cited by 240
Self-citationCelsi, G., Kistner, A., Aizman, R., EklÖF, A.-C., Ceccatelli, S., De Santiago, A., & Jacobson, S. H. (1998) · Pediatric Research · doi:10.1203/00006450-199809000-00009 · Cited by 239
Wudy, S. A., Schuler, G., Sánchez-Guijo, A., & Hartmann, M. F. (2018) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.09.003 · Cited by 236
Self-citationGender development in women with congenital adrenal hyperplasia as a function of disorder severity
Meyer-Bahlburg, H. F. L., Dolezal, C., Baker, S. W., Ehrhardt, A. A., & New, M. I. (2006) · Archives of Sexual Behavior · doi:10.1007/s10508-006-9068-9 · Cited by 234
Turcu, A. F., Nanba, A. T., Chomic, R., Upadhyay, S. K., Giordano, T. J., Shields, J. J., Merke, D. P., Rainey, W. E., & Auchus, R. J. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-1181 · Cited by 231
Self-citationMolecular Endocrinology of Hydroxysteroid Dehydrogenases
Penning, T. M. (1997) · Endocrine Reviews · doi:10.1210/er.18.3.281 · Cited by 230
Characterization of frequent deletions causing steroid 21-hydroxylase deficiency
White, P. C., Vitek, A., Dupont, B., & New, M. I. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.12.4436 · Cited by 229
Self-citationHirvikoski, T., Nordenström, A., Lindholm, T., Lindblad, F., Ritzén, E. M., Wedell, A., & Lajic, S. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1340 · Cited by 228
Self-citationAdrenal incidentaloma and patients with homozygous or heterozygous congenital adrenal hyperplasia.
Jaresch, S., Kornely, E., Kley, H. K., & Schlaghecke, R. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.74.3.1311000 · Cited by 227
Rege, J., Nakamura, Y., Satoh, F., Morimoto, R., Kennedy, M. R., Layman, L. C., Honma, S., Sasano, H., & Rainey, W. E. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2912 · Cited by 227
Steroidogenesis: Unanswered Questions
Miller, W. L. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2017.09.002 · Cited by 226
Self-citationPlat, L., Leproult, R., L’Hermite-Baleriaux, M., Fery, F., Mockel, J., Polonsky, K. S., & Van Cauter, E. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.9.5978 · Cited by 225
Biswas, M. G., & Russell, D. W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.25.15959 · Cited by 224
Newborn screening for congenital adrenal hyperplasia
Therrell, B. L. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(08)70017-3 · Cited by 221
Lum, A., Wakefield, C. E., Donnan, B., Burns, M. A., Fardell, J. E., & Marshall, G. M. (2017) · Child: Care, Health and Development · doi:10.1111/cch.12475 · Cited by 221
Matern, D., Tortorelli, S., Oglesbee, D., Gavrilov, D., & Rinaldo, P. (2007) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-007-0691-y · Cited by 217
Trautman, P. D., Meyer-Bahlburg, H. F. L., Postelnek, J., & New, M. I. (1995) · Psychoneuroendocrinology · doi:10.1016/0306-4530(94)00070-0 · Cited by 217
11-Oxygenated androgens in health and disease
Turcu, A. F., Rege, J., Auchus, R. J., & Rainey, W. E. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0336-x · Cited by 217
Self-citationIntegrated view on 17beta-hydroxysteroid dehydrogenases
Moeller, G., & Adamski, J. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.10.040 · Cited by 214
Bidet, M., Bellanné-Chantelot, C., Galand-Portier, M.-B., Tardy, V., Billaud, L., Laborde, K., Coussieu, C., Morel, Y., Vaury, C., Golmard, J.-L., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1582 · Cited by 213
Self-citation11 -Hydroxysteroid Dehydrogenase and the Syndrome of Apparent Mineralocorticoid Excess
White, P. C. (1997) · Endocrine Reviews · doi:10.1210/er.18.1.135 · Cited by 213
Self-citationIsidori, A. M., Venneri, M. A., Graziadio, C., Simeoli, C., Fiore, D., Hasenmajer, V., Sbardella, E., Gianfrilli, D., Pozza, C., Pasqualetti, P., et al. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30398-4 · Cited by 211
Psychological interventions for parents of children and adolescents with chronic illness
Law, E., Fisher, E., Eccleston, C., & Palermo, T. M. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009660.pub4 · Cited by 207
Transition Care for Children With Special Health Care Needs
Davis, A. M., Brown, R. F., Taylor, J. L., Epstein, R. A., & McPheeters, M. L. (2014) · Pediatrics · doi:10.1542/peds.2014-1909 · Cited by 206
Speiser, P. W., New, M. I., & White, P. C. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807073190104 · Cited by 205
Self-citationNordenskjöld, A., Holmdahl, G., Frisén, L., Falhammar, H., Filipsson, H., Thorén, M., Janson, P. O., & Hagenfeldt, K. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0556 · Cited by 205
Self-citationHagenfeldt, K., Janson, P. O., Holmdahl, G., Falhammar, H., Filipsson, H., Frisen, L., Thoren, M., & Nordenskjold, A. (2008) · Human Reproduction · doi:10.1093/humrep/den118 · Cited by 205
Disorders in the initial steps of steroid hormone synthesis
Miller, W. L. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.03.009 · Cited by 205
Self-citationFalhammar, H., Frisén, L., Hirschberg, A. L., Norrby, C., Almqvist, C., Nordenskjöld, A., & Nordenström, A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2093 · Cited by 204
Self-citationLong Term Outcome in Adult Males with Classic Congenital Adrenal Hyperplasia1
Cabrera, M. S., Vogiatzi, M. G., & New, M. I. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.7.7668 · Cited by 204
Fertility in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Bidet, M., Bellanné-Chantelot, C., Galand-Portier, M.-B., Golmard, J.-L., Tardy, V., Morel, Y., Clauin, S., Coussieu, C., Boudou, P., Mowzowicz, I., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1383 · Cited by 204
Self-citationMercado, A. B. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.7.2014 · Cited by 203
Carmina, E., Dewailly, D., Escobar-Morreale, H. F., Kelestimur, F., Moran, C., Oberfield, S., Witchel, S. F., & Azziz, R. (2017) · Human Reproduction Update · doi:10.1093/humupd/dmx014 · Cited by 201
Holmes, M. C., Abrahamsen, C. T., French, K. L., Paterson, J. M., Mullins, J. J., & Seckl, J. R. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4464-05.2006 · Cited by 200
Huang, N., Agrawal, V., Giacomini, K. M., & Miller, W. L. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711621105 · Cited by 198
Self-citationIncreased mortality in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Falhammar, H., Frisén, L., Norrby, C., Hirschberg, A. L., Almqvist, C., Nordenskjöld, A., & Nordenström, A. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2957 · Cited by 196
Self-citationGonadal and Adrenal Androgens Are Potent Regulators of Human Bone Cell Metabolism In Vitro
Kasperk, C. H., Wakley, G. K., Hierl, T., & Ziegler, R. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.3.464 · Cited by 196
Baker, B. Y., Lin, L., Kim, C. J., Raza, J., Smith, C. P., Miller, W. L., & Achermann, J. C. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1565 · Cited by 194
Self-citationFinkielstain, G. P., Chen, W., Mehta, S. P., Fujimura, F. K., Hanna, R. M., Van Ryzin, C., McDonnell, N. B., & Merke, D. P. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0319 · Cited by 192
Self-citationThe orphan nuclear receptors NURR1 and NGFIB regulate adrenal aldosterone production
Bassett, M. H., Suzuki, T., Sasano, H., White, P. C., & Rainey, W. E. (2004) · Molecular Endocrinology · doi:10.1210/me.2003-0005 · Cited by 192
Self-citationKamrath, C., Hochberg, Z., Hartmann, M. F., Remer, T., & Wudy, S. A. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1997 · Cited by 191
Self-citationMerke, D. P., Keil, M. F., Jones, J. V., Fields, J., Hill, S., & Cutler, G. B. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.3.6462 · Cited by 190
Self-citationCasteràs, A., De Silva, P., Rumsby, G., & Conway, G. S. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03563.x · Cited by 190
Laue, K., Pogoda, H.-M., Daniel, P. B., van Haeringen, A., Alanay, Y., von Ameln, S., Rachwalski, M., Morgan, T., Gray, M. J., Breuning, M. H., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.09.015 · Cited by 188
Blanchong, C. A., Zhou, B., Rupert, K. L., Chung, E. K., Jones, K. N., Sotos, J. F., Zipf, W. B., Rennebohm, R. M., & Yu, C. Y. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.12.2183 · Cited by 187
Gidlöf, S., Falhammar, H., Thilén, A., von Döbeln, U., Ritzén, M., Wedell, A., & Nordenström, A. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70007-x · Cited by 187
Self-citationSimpson, J. L. (1993) · JAMA · doi:10.1001/jama.270.19.2357 · Cited by 187
Moran, C., Azziz, R., Carmina, E., Dewailly, D., Fruzzetti, F., Ibañez, L., Knochenhauer, E. S., Marcondes, J. A. M., Mendonca, B. B., Pignatelli, D., et al. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2000.108020 · Cited by 185
Self-citationYang, Z., Mendoza, A. R., Welch, T. R., Zipf, W. B., & Yu, C. Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.12147 · Cited by 184
Tusie-Luna, M.-T., Speiser, P. W., Dumic, M., New, M. I., & White, P. C. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-5-685 · Cited by 183
Self-citationAdult Height in Patients with Congenital Adrenal Hyperplasia: A Systematic Review and Metaanalysis
Muthusamy, K., Elamin, M. B., Smushkin, G., Murad, M. H., Lampropulos, J. F., Elamin, K. B., Abu Elnour, N. O., Gallegos-Orozco, J. F., Fatourechi, M. M., Agrwal, N., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2616 · Cited by 182
Tusié-Luna, M. T., & White, P. C. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10796 · Cited by 179
Self-citationAlternative (backdoor) androgen production and masculinization in the human fetus
O’Shaughnessy, P. J., Antignac, J. P., Le Bizec, B., Morvan, M.-L., Svechnikov, K., Söder, O., Savchuk, I., Monteiro, A., Soffientini, U., Johnston, Z. C., et al. (2019) · PLOS Biology · doi:10.1371/journal.pbio.3000002 · Cited by 177
Plat, L. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.9.3082 · Cited by 177
HAGUE, W. M., ADAMS, J., RODDA, C., BROOK, C. G. D., DE BRUYN, R., GRANT, D. B., & JACOBS, H. S. (1990) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1990.tb03887.x · Cited by 175
Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia
Moran, C., Azziz, R., Weintrob, N., Witchel, S. F., Rohmer, V., Dewailly, D., Marcondes, J. A. M., Pugeat, M., Speiser, P. W., Pignatelli, D., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0062 · Cited by 174
Self-citationSteroidogenic Enzyme Gene Expression in the Human Heart
Kayes, K. M., & White, P. C. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6663 · Cited by 174
Steroidogenic enzyme gene expression in the human heart
Kayes-Wandover, K. M. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.7.2519 · Cited by 174
Flück, C. E., Miller, W. L., & Auchus, R. J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030143 · Cited by 173
Self-citationWilson, J. D., Auchus, R. J., Leihy, M. W., Guryev, O. L., Estabrook, R. W., Osborn, S. M., Shaw, G., & Renfree, M. B. (2003) · Endocrinology · doi:10.1210/en.2002-220721 · Cited by 172
Self-citationStikkelbroeck, N. M. M. L., Hoefsloot, L. H., de Wijs, I. J., Otten, B. J., Hermus, A. R. M. M., & Sistermans, E. A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021681 · Cited by 171
Self-citationHigh prevalence of reduced fecundity in men with congenital adrenal hyperplasia
Reisch, N., Flade, L., Scherr, M., Rottenkolber, M., Pedrosa Gil, F., Bidlingmaier, M., Wolff, H., Schwarz, H.-P., Quinkler, M., Beuschlein, F., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1414 · Cited by 170
Self-citationRauh, M., Gröschl, M., Rascher, W., & Dörr, H. G. (2006) · Steroids · doi:10.1016/j.steroids.2006.01.015 · Cited by 170
Falhammar, H., Nyström, H. F., Ekström, U., Granberg, S., Wedell, A., & Thorén, M. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-0828 · Cited by 170
Self-citationDiagnosis of the adrenogenital syndrome before birth
Jeffcoate, T. N. A., Fliegner, J. R. H., Russell, S., Davis, J. C., & Wade, A. P. (1965) · The Lancet · doi:10.1016/s0140-6736(65)90864-0 · Cited by 169
Mallappa, A., Sinaii, N., Kumar, P., Whitaker, M. J., Daley, L.-A., Digweed, D., Eckland, D. J. A., Van Ryzin, C., Nieman, L. K., Arlt, W., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3809 · Cited by 167
Self-citationFalhammar, H., Filipsson, H., Holmdahl, G., Janson, P.-O., Nordenskjöld, A., Hagenfeldt, K., & Thorén, M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1350 · Cited by 167
Mullins, L. L., Wolfe-Christensen, C. B., Pai, A. L. H., Carpentier, M. Y., Gillaspy, S. R., Cheek, J., & Page, M. C. (2007) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsm044 · Cited by 167
Bonfig, W., Bechtold, S., Schmidt, H., Knorr, D., & Schwarz, H. P. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2109 · Cited by 167
Comprehensive cost-utility analysis of newborn screening strategies
Carroll, A. E., & Downs, S. M. (2006) · PEDIATRICS · doi:10.1542/peds.2005-2633h · Cited by 165
Long-Term Somatic Follow-Up of Prenatally Treated Children with Congenital Adrenal Hyperplasia1
Lajic, S., Wedell, A., Bui, T.-H., Ritzén, E. M., & Holst, M. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.11.5233 · Cited by 164
Genotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency
Krone, N., Reisch, N., Idkowiak, J., Dhir, V., Ivison, H. E., Hughes, B. A., Rose, I. T., O'Neil, D. M., Vijzelaar, R., Smith, M. J., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0640 · Cited by 163
Self-citationEngels, M., Span, P. N., van Herwaarden, A. E., Sweep, F. C. G. J., Stikkelbroeck, N. M. M. L., & Claahsen-van der Grinten, H. L. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00258 · Cited by 163
Self-citationArtificial intelligence (AI) in rare diseases: is the future brighter?
Brasil, S., Pascoal, C., Francisco, R., dos Reis Ferreira, V., A. Videira, P., & Valadão, G. (2019) · Genes · doi:10.3390/genes10120978 · Cited by 160
Wong, T., Shackleton, C. H., Covey, T. R., & Ellis, G. (1992) · Clinical Chemistry · doi:10.1093/clinchem/38.9.1830 · Cited by 159
Nordenström, A., & Falhammar, H. (2019) · European Journal of Endocrinology · doi:10.1530/eje-18-0712 · Cited by 158
Self-citationCrudo, A., Petropoulos, S., Moisiadis, V. G., Iqbal, M., Kostaki, A., Machnes, Z., Szyf, M., & Matthews, S. G. (2012) · Endocrinology · doi:10.1210/en.2011-2160 · Cited by 156
Fukami, M., Horikawa, R., Nagai, T., Tanaka, T., Naiki, Y., Sato, N., Okuyama, T., Nakai, H., Soneda, S., Tachibana, K., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0810 · Cited by 155
Minutti, C. Z., Lacey, J. M., Magera, M. J., Hahn, S. H., McCann, M., Schulze, A., Cheillan, D., Dorche, C., Chace, D. H., Lymp, J. F., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032235 · Cited by 154
Rege, J., Turcu, A., Kasa-Vubu, J. Z., Lerario, A. M., Auchus, G. C., Auchus, R. J., Smith, J. M., White, P. C., & Rainey, W. E. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00736 · Cited by 154
Self-citationHomma, K., Hasegawa, T., Nagai, T., Adachi, M., Horikawa, R., Fujiwara, I., Tajima, T., Takeda, R., Fukami, M., & Ogata, T. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2460 · Cited by 153
Wilson, R. C., Nimkarn, S., Dumić, M., Obeid, J. S., Azar, M. R., Najmabadi, H., Saffari, F., & New, M. I. (2007) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2006.12.005 · Cited by 152
Children with disorders of sex development: A qualitative study of early parental experience
Crissman, H. P., Warner, L., Gardner, M., Carr, M., Schast, A., Quittner, A. L., Kogan, B., & Sandberg, D. E. (2011) · International Journal of Pediatric Endocrinology · doi:10.1186/1687-9856-2011-10 · Cited by 152
Self-citationFractures and bone mineral density in adult women with 21-hydroxylase deficiency
Falhammar, H., Filipsson, H., Holmdahl, G., Janson, P.-O., Nordenskjöld, A., Hagenfeldt, K., & Thorén, M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0744 · Cited by 151
Self-citationThilén, A., Nordenström, A., Hagenfeldt, L., von Döbeln, U., Guthenberg, C., & Larsson, A. (1998) · PEDIATRICS · doi:10.1542/peds.101.4.e11 · Cited by 151
A missense mutation at Ile172----Asn or Arg356----Trp causes steroid 21-hydroxylase deficiency.
Chiou, S. H., Hu, M. C., & Chung, B. C. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39804-7 · Cited by 149
Jääskeläinen, J., Levo, A., Voutilainen, R., & Partanen, J. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.10.4271 · Cited by 149
Disorders of sex development (DSDs), their presentation and management in different cultures
Warne, G. L., & Raza, J. (2008) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9084-2 · Cited by 149
Clinical perspectives in congenital adrenal hyperplasia due to 11β-hydroxylase deficiency
Bulsari, K., & Falhammar, H. (2016) · Endocrine · doi:10.1007/s12020-016-1189-x · Cited by 149
Self-citationSeçinti, E., Thompson, E. J., Richards, M., & Gaysina, D. (2017) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12727 · Cited by 149
Physiological partial aldosterone resistance in human newborns
Martinerie, L., Pussard, E., Foix-L'Hélias, L., Petit, F., Cosson, C., Boileau, P., & Lombès, M. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e3181b1bbec · Cited by 148
Koetz, K., Ventz, M., Diederich, S., & Quinkler, M. O. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2036 · Cited by 148
Merke, D. P., Bornstein, S. R., Avila, N. A., & Chrousos, G. P. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-4-200202190-00012 · Cited by 147
Self-citationCyproterone Acetate Versus Hydrocortisone Treatment in Late-Onset Adrenal Hyperplasia
SPRITZER, P., BILLAUD, L., THALABARD, J.-C., BIRMAN, P., MOWSZOWICZ, I., RAUX-DEMAY, M.-C., CLAIR, F., KUTTENN, F., & MAUVAIS-JARVIS, P. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-3-642 · Cited by 146
Research works printed but not linked: 2
- McCann-Crosby, 2014, Non classic CAH; targets of treatment and transition, Pediatr Endocr Rev., 12, 224
- Auchus, 2012, Abiraterone acetate added to physiologic hydrocortisone dosing safely controls androgen excess in adult women with classical 21-hydroxylase deficiency, Endocr Rev., 33, SUN-LB2
Cited by
Overview of the 2022 WHO Classification of Adrenal Cortical Tumors
Mete, O., Erickson, L. A., Juhlin, C. C., de Krijger, R. R., Sasano, H., Volante, M., & Papotti, M. G. (2022) · Endocrine Pathology · doi:10.1007/s12022-022-09710-8 · Cited by 343
Clinical practice guidelines for the care of girls and women with Turner syndrome.
Gravholt, C. H., Andersen, N. H., Christin-Maitre, S., Davis, S. M., Duijnhouwer, A., Gawlik, A., Maciel-Guerra, A. T., Gutmark-Little, I., Fleischer, K., Hong, D., et al. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae050 · Cited by 224
Self-citationManagement challenges and therapeutic advances in congenital adrenal hyperplasia
Mallappa, A., & Merke, D. P. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00655-w · Cited by 113
Self-citationGlucocorticoids and cognitive function: a walkthrough in endogenous and exogenous alterations
Alcubierre, D. D., Ferrari, D., Mauro, G. C. D., Isidori, A. M., Tomlinson, J., & Pofi, R. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02091-7 · Cited by 77
“In the most severe Salt-Wasting (SW-CAH) form, there is little or no residual enzyme activity, whereas patients with the Simple-Virilizing (SV-CAH) form still retain 1–5% enzyme activity [153].”
BackgroundPhase 3 Trial of Crinecerfont in Adult Congenital Adrenal Hyperplasia
Auchus, R. J., Hamidi, O., Pivonello, R., Bancos, I., Russo, G., Witchel, S. F., Isidori, A. M., Rodien, P., Srirangalingam, U., Kiefer, F. W., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2404656 · Cited by 79
Self-citation
Metadata
- Authors
- Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., Krone, N., Merke, D. P., Miller, W. L., Nordenström, A., Reisch, N., Sandberg, D. E., Stikkelbroeck, N. M. M. L., Touraine, P., Utari, A., Wudy, S. A., & White, P. C.
- Affiliations
- Department of Pediatric Endocrinology, Radboud University Medical Centre, Amalia Childrens Hospital, Nijmegen, The Netherlands
- Northwell Health (US)
- University of Glasgow (GB)
- University Hospitals Birmingham NHS Foundation Trust (GB)
- University of Michigan (US)
- Karolinska University Hospital (SE)
- University of Bern (CH)
- Queen Mary University of London (GB)
- Technische Universität Dresden (DE)
- Radboud University Medical Center (NL)
- University Hospital Carl Gustav Carus (DE)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (US)
- University of California, San Francisco (US)
- LMU Klinikum (DE)
- Sorbonne Université (FR)
- Diponegoro University (ID)
- Justus-Liebig-Universität Gießen (DE)
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- White, Perrin C
- ORCID
- Claahsen - van der Grinten, Hedi L
- Speiser, Phyllis W
- Ahmed, S Faisal
- Arlt, Wiebke
- Auchus, Richard J
- Falhammar, Henrik
- Flück, Christa E
- Guasti, Leonardo
- Huebner, Angela
- Krone, Nils
- Merke, Deborah P
- Miller, Walter L
- Nordenström, Anna
- Reisch, Nicole
- Sandberg, David E
- Touraine, Philippe
- Utari, Agustini
- Wudy, Stefan A
- White, Perrin C
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2021-05-07
- Volume
- 43
- Issue
- 1
- Pages
- 91-159
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W4229036110
- Semantic Scholar
- 1867a4639fab9f23f14102ccc6107c07963e64dc
- Cited by
- 556
- References
- 831
- Citations by year
- 2026: 102 · 2025: 125 · 2024: 149 · 2023: 97 · 2022: 68 · 2021: 14
- FWCI
- 8.59
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Endocrine Reviews (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, other-oa)
- Queen Mary Research Online (Queen Mary University of London) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- National Institutes of Health (U01-HD083493)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- congenital adrenal hyperplasia, 21-hydroxylase deficiency, CYP21A2 mutations, cortisol production, steroidogenic pathway, newborn screening, steroid profiling, genotyping, cell therapy, gene therapy, long-term outcomes, disease registries
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.